Figure 3
From: Does route of administration affect the outcome of TNF antagonist therapy?
In a survey of 141 patients with rheumatoid arthritis, 63% indicated a preference for the administration of medication intravenously (IV) and 37% indicated a preference for administration subcutaneously (SC). *Preferred someone else to inject the medication. †Preferred self-injection. Adapted, with permission, from [21].